Association between prolactin/testosterone ratio and breast cancer in Chinese women
Chin Med J (Engl)
.
2024 Feb 5;137(3):368-370.
doi: 10.1097/CM9.0000000000002942.
Epub 2024 Jan 11.
Authors
Qian Cai
1
2
3
,
Xiaohan Tian
4
,
Yuyi Tang
5
,
Han Cong
6
,
Jie Liu
4
,
Song Zhao
4
7
,
Rong Ma
4
,
Jianli Wang
8
,
Jiang Zhu
4
7
Affiliations
1
Department of Geriatric Medicine, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China.
2
Key Laboratory of Cardiovascular Proteomics of Shandong Province, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China.
3
Department of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong 250012, China.
4
Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China.
5
Department of Thyroid and Breast Surgery, Guangdong Second Provincial General Hospital, Guangzhou, Guangdong 510310, China.
6
Department of Toxicology and Cancer Biology, Collage of Medicine, University of Kentucky, Lexington, KY 40536, USA.
7
Department of Immunology, School of Basic Medical Science, Shandong University, Jinan, Shandong 250012, China.
8
Department of Gynaecology and Obstetrics, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China.
PMID:
38200638
PMCID:
PMC10836897
DOI:
10.1097/CM9.0000000000002942
No abstract available
MeSH terms
Breast Neoplasms*
China
Estradiol
Female
Humans
Prolactin
Testosterone
Testosterone Congeners
Substances
Testosterone
Prolactin
Estradiol
Testosterone Congeners